Sana Biotechnology, Inc. (SANA)
Sana Biotechnology, Inc. is a biotechnology firm focused on creating treatments using engineered cells. The company develops advanced ex vivo and in vivo cell engineering platforms to address a range of conditions with significant unmet medical needs, including various cancers, diabetes, central nervous system disorders, cardiovascular diseases, and genetic illnesses. Its portfolio of drug candidates includes SG295 and SG242, which are designed to target CD19+ cancer cells involved in non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia. For multiple myeloma, Sana is progressing SG221, SG239, and SC255. Other pipeline assets include SG328 for ornithine transcarbamylase deficiency, and SG418 for sickle cell disease and beta-thalassemia. Additionally, the company is advancing SC291, a CD19 allogeneic T cell therapy, SC451 for type I diabetes mellitus, and SC379 for secondary progressive multiple sclerosis, Pelizaeus-Merzbacher disease, and Huntington's disease. Founded in 2018 as FD Therapeutics, Inc., the company adopted its current name, Sana Biotechnology, Inc., in September 2018 and is based in Seattle, Washington.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Sana Biotechnology, Inc.
NASDAQ:SANAHealthcare · Biotechnology
-1.69%$2.33
AH Close$2.35+0.86%vs close
AH Close$2.35+0.86%vs close
Mkt Cap$697.51M
Float151.61M
O/S299.36M
Inst Own61.7%
SI25.5%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$244.17M
Total Assets$416.89M
Free Cash Flow-$144.77M
Debt & Equity
Debt 33%
Equity 67%
Total Debt$78.86M
Total Equity$160.88M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in SANA's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$416.89M
Liabilities$256.01M
Accounts Receivable$0
Accounts Payable$1.67M
Inventory$0
PP&E (Net)$65.22M
Goodwill$140.63M
Intangible Assets$59.2M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - |
| Cost of Revenue | $12.75M | $0 | $0 | $0 | $0 | $10.17M | $3.92M | $1K |
| Gross Profit | -$12.75M | $0 | $0 | $0 | $0 | -$10.17M | -$3.92M | -$1K |
| Gross Margin | - | - | - | - | - | - | - | - |
| Research and Development | $131.98M | $208.68M | $219.84M | $201M | $306.5M | $122.68M | $119.38M | $4.01M |
| Selling, General, and Administrative | $44.3M | $64.04M | $73.3M | $71.56M | $50.41M | $28.27M | $21.78M | $4.21M |
| Other | $1.93M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $178.21M | $272.72M | $293.14M | $272.56M | $356.91M | $150.95M | $141.15M | $8.22M |
| Operating Income (EBIT) | -$190.96M | -$272.72M | -$293.14M | -$272.56M | -$356.91M | -$161.12M | -$141.15M | -$8.22M |
| Operating Margin | - | - | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $3.85M | $10.47M | $9.94M | $3.76M | $676K | $747K | $2.86M | $0 |
| Other Income (Expense) | -$53.21M | $5.96M | $9.89M | $3.09M | $981K | -$136.08M | $2.83M | -$5.03M |
| Income Before Tax (EBT) | -$244.17M | -$266.76M | -$283.25M | -$269.48M | -$355.93M | -$297.2M | -$138.32M | -$13.25M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | -$11.9M | -$7.55M | $0 |
| Net Income | -$244.17M | -$266.76M | -$283.25M | -$269.48M | -$355.93M | -$285.31M | -$130.78M | -$13.25M |
| Net Income Margin | - | - | - | - | - | - | - | - |
| Supplementary Data | ||||||||
| EPS | -0.96 | -1.16 | -1.46 | -1.43 | -2.14 | -1.63 | -0.70 | -0.07 |
| Diluted EPS | -0.96 | -1.16 | -1.46 | -1.43 | -2.14 | -1.63 | -0.70 | -0.07 |
| Weighted Average OS | 253.23M | 230.89M | 194.54M | 188.34M | 166.43M | 187.51M | 187.34M | 187.34M |
| EBITDA | -$231.42M | -$251.26M | -$258.7M | -$253.85M | -$344.86M | -$291.28M | -$141M | -$13.25M |
| EBITDA Margin | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $71.87M | $127.57M | $133.52M | $176.76M | $253.03M | $124.81M | $80.03M | $30.63M |
| Short-Term Investments | $66.51M | $24.93M | $71.68M | $247.2M | $297.97M | $253.46M | $58.95M | $0 |
| Cash and Short-Term Investments | $138.38M | $152.5M | $205.19M | $423.96M | $551M | $378.26M | $138.98M | $30.63M |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $10.29M | $8.31M | $8.32M | $20.47M | $0 | $0 | $0 | $0 |
| Total Current Assets | $148.68M | $160.81M | $213.51M | $444.44M | $558.1M | $384.47M | $144.26M | $32.6M |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $65.22M | $135.27M | $145.59M | $159.4M | $161.78M | $109.94M | $68.81M | $585K |
| Goodwill | $140.63M | $140.63M | $140.63M | $140.63M | $140.63M | $140.63M | $140.63M | $0 |
| Intangible Assets | $59.2M | $59.2M | $59.2M | $59.2M | $59.2M | $59.2M | $59.2M | $0 |
| Long-Term Investments | $0 | $0 | $0 | $10.05M | $195.88M | $33.73M | $0 | $816K |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $3.17M | $5.12M | $6.37M | $9.01M | $13.82M | $2.33M | $2.3M | $336K |
| Total Long-Term Assets | $268.21M | $340.21M | $351.78M | $378.28M | $571.31M | $345.83M | $270.93M | $1.74M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $416.89M | $501.02M | $565.3M | $822.72M | $1.13B | $730.3M | $415.19M | $34.33M |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $1.67M | $5.21M | $4.11M | $2.86M | $2.22M | $2.25M | $0 | $289K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $51.93M | $300K | $23.46M | $76.59M | $74.63M | $14.02M | $8.09M | $685K |
| Total Current Liabilities | $78.73M | $45.43M | $64.49M | $111.5M | $99.23M | $31.45M | $19.32M | $1.78M |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $113.36M | $123.42M | $122.41M | $116.04M | $199.89M | $1.05B | $492.05M | $45.74M |
| Total Long-Term Liabilities | $177.28M | $205.08M | $213.31M | $211.9M | $301.67M | $1.12B | $538.41M | $45.74M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $256.01M | $250.52M | $277.79M | $323.4M | $400.9M | $1.15B | $557.73M | $47.52M |
| Stockholders' Equity | ||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $45.72M |
| Common Stock | $27K | $22K | $20K | $19K | $18K | $2K | $1K | $1K |
| Retained Earnings | -$1.85B | -$1.6B | -$1.34B | -$1.05B | -$785.36M | -$429.43M | -$144.13M | -$13.25M |
| Comprehensive Income & Other | $28K | $14K | -$60K | -$4.33M | -$1.37M | $30K | $26K | -$45.72M |
| Other Stockholders' Equity | $2.01B | $1.86B | $1.63B | $1.55B | $1.51B | $8.25M | $1.58M | $58K |
| Total Equity | $160.88M | $250.5M | $287.51M | $499.31M | $728.5M | -$421.18M | -$142.54M | -$13.19M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $416.89M | $501.02M | $565.3M | $822.72M | $1.13B | $730.3M | $415.19M | $34.33M |
| Supplementary Data | ||||||||
| Total Debt | $78.86M | $94.2M | $104.1M | $108.25M | $110.94M | $71.91M | $47.7M | $0 |
| Net Debt | $6.99M | -$33.37M | -$29.42M | -$68.51M | -$142.09M | -$52.9M | -$32.33M | -$30.63M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Operating Activities | ||||||||
| Net Income | -$244.17M | -$266.76M | -$283.25M | -$269.48M | -$355.93M | -$285.31M | -$130.78M | -$13.25M |
| Depreciation & Amortization | $12.75M | $15.5M | $24.56M | $15.63M | $11.07M | $5.92M | $1.83M | $1K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | -$7.55M | $0 |
| Stock-Based Compensation | $25.46M | $37.68M | $35.53M | $38.34M | $22.36M | $5.83M | $1.5M | $118K |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | -$3.54M | $1.38M | $1.03M | $1.06M | -$266K | $1.98M | -$421K | $289K |
| Other Working Capital | -$6.57M | -$2.56M | $17.58M | $6.48M | $10.07M | $4.17M | $10.95M | -$597K |
| Total Working Capital Change | -$10.11M | -$1.19M | $18.61M | $7.54M | $9.8M | $6.16M | $10.53M | -$308K |
| Other Non-Cash Items | $72.24M | -$8.39M | -$49.03M | -$82.08M | $61.64M | $129.42M | $38.97M | -$228K |
| Net Cash from Operating | -$143.83M | -$223.15M | -$253.58M | -$290.05M | -$251.05M | -$137.98M | -$85.5M | -$13.49M |
| Investing Activities | ||||||||
| Capital Expenditures | -$938K | -$33.43M | -$20.03M | -$20.88M | -$29.86M | -$23.87M | -$26.18M | -$460K |
| Acquisitions | $1.43M | $0 | -$192K | -$231K | $0 | $0 | -$3.19M | $0 |
| Purchases of Investments | -$87.29M | -$226.06M | -$157.74M | -$78.69M | -$491.39M | -$387.43M | -$141.52M | $0 |
| Sales of Investments | $46.56M | $276.95M | $349.79M | $310.13M | $280.02M | $158.74M | $82.98M | $0 |
| Other Investing Activities | $0 | $0 | $192K | $231K | -$4.57M | $0 | $59K | -$320K |
| Net Cash from Investing | -$40.24M | $17.45M | $172.01M | $210.56M | -$245.8M | -$252.56M | -$87.86M | -$780K |
| Financing Activities | ||||||||
| Debt Repaid | $347K | -$188.74M | - | - | - | - | - | - |
| Common Stock Issuance | $129.08M | $192M | $31.65M | $4.91M | $631.75M | $0 | $1K | $45.72M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | -$181M | $0 | $0 | $0 | $149K | -$14K | $0 |
| Net Cash from Financing | $128.73M | $199.75M | $31.65M | $4.91M | $631.75M | $435.69M | $223.73M | $45.72M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$55.33M | -$5.95M | -$49.92M | -$74.58M | $134.9M | $45.14M | $50.36M | $31.45M |
| Supplementary Data | ||||||||
| Operating Cash Flow | -$143.83M | -$223.15M | -$253.58M | -$290.05M | -$251.05M | -$137.98M | -$85.5M | -$13.49M |
| Capital Expenditure | -$938K | -$33.43M | -$20.03M | -$20.88M | -$29.86M | -$23.87M | -$26.18M | -$460K |
| Free Cash Flow | -$144.77M | -$256.58M | -$273.61M | -$310.93M | -$280.92M | -$161.85M | -$111.69M | -$13.96M |
| Cash at Beginning | $131.4M | $137.35M | $187.27M | $261.85M | $126.95M | $81.81M | $31.45M | -$816K |
| Cash at End | $76.06M | $131.4M | $137.35M | $187.27M | $261.85M | $126.95M | $81.81M | $30.63M |